Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Centre for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden.
Ann Clin Transl Neurol. 2020 Jan;7(1):139-143. doi: 10.1002/acn3.50972. Epub 2020 Jan 1.
Blood Neurofilament light chain (NfL) has been suggested as a promising biomarker in several neurological conditions. Since blood NfL is the consequence of leaked NfL from the cerebrospinal fluid, differences in individuals' Body Mass Index (BMI) or blood volume (BV) might affect its correlation to other biomarkers and disease outcomes. Here, we investigated the correlation between plasma NfL, BMI, and BV in 662 controls and 2,586 multiple sclerosis cases. We found a significant negative correlation between plasma NfL, BMI/BV in both groups. Our results highlight the potential confounding effect of BMI/BV on associations between blood NfL and disease outcomes.
血液神经丝轻链(NfL)已被认为是几种神经疾病有前途的生物标志物。由于血液 NfL 是脑脊液中漏出的 NfL 的结果,个体的体重指数(BMI)或血容量(BV)的差异可能会影响其与其他生物标志物和疾病结果的相关性。在这里,我们研究了 662 名对照和 2586 名多发性硬化症患者的血浆 NfL、BMI 和 BV 之间的相关性。我们发现两组的血浆 NfL 与 BMI/BV 呈显著负相关。我们的研究结果强调了 BMI/BV 对血液 NfL 与疾病结果之间关联的潜在混杂影响。